Jennifer Green, MD, is a professor of medicine and endocrinologist at Duke University and a member of the Duke Clinical Research Institute (DCRI). Her research has focused upon strategies to treat diabetes and reduce the risk of cardiovascular and other complications. She has served as an investigator in federally funded clinical trials of glycemic management in type 2 diabetes including ACCORD, BARI 2D, and GRADE. Her work with the DCRI has included leadership of several international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, and Harmony Outcomes), and she is now the US coordinating center PI for the EMPA-Kidney trial. Dr. Green is also a member of the ADA Professional Practice Committee, which publishes the annual Standards of Care in Diabetes.
Susan Spratt, MD, Associate Professor of Medicine and Assistant Professor of Community and Family Medicine. Dr. Spratt’s research focuses on management of diabetes, population health and diabetes, and informatics and clinical decision support for diabetes and other chronic diseases. This work includes developing phenotypes for diabetes identification in secondary data analysis; identifying patient perceptions and ethical issues involved in secondary data analysis; using geospatial analysis, risk assessment and community engagement to reduce death and disability in patients with diabetes.
Matt Crowley, MD,MHS, is a Duke University Professor of Medicine with Tenure (Endocrinology), a Staff Physician at the Durham VA Medical Center, and a Core Investigator at the Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation. His work seeks to improve chronic disease outcomes through the development, testing, and implementation of practical health services interventions for individuals that respond suboptimally to standard care. Dr. Crowley is currently PI or Multiple PI on an NIH R01 award, a VA Quality Enhancement Research Initiative Center grant, and a national VA Office of Rural Health Enterprise-Wide Initiative implementation program; he has additionally served as a Co-I on numerous NIH-, VA-, and PCORI-funded projects. He has >110 peer-reviewed publications. He is also a dedicated medical educator, currently serving as Director for Duke’s Endocrinology Fellowship Program, Associate Director for Duke’s Endocrinology T32 Training Grant, and Co-Director of the Duke Department of Medicine Research Development Council.
Bryan Batch, MD, Assistant Professor of Medicine. Dr. Batch works on the design, adaptation and implementation of behavioral lifestyle interventions targeted to overweight, obese and diabetic people. Her focus is on variation in the demographics and responses among different patient groups and how to explain and correct.
Richard Lee, MD, MPH, Assistant Professor of Medicine. Dr Lee is a dual-trained Geriatrician and Endocrinologist with expertise in metabolic bone disease including osteoporosis. His primary research focuses on the interaction of comorbidities with bone health and bone fractures. Dr. Lee, along with collaborators from the Duke Molecular Physiology Institute, the Department of Biomedical Engineering, and the Duke Center for Aging, have identified factors associated with fracture risk among older adults with diabetes. He also works within the Bone Health Service at the Durham VA GRECC developing approaches to enhance screening and treatment of osteoporosis in male Veterans. Dr. Lee’s work has been supported by the American Diabetes Association, John A. Hartford Foundation/AFAR, Department of Veterans Affairs, and the NIH National Institute on Aging.
Diana McNeill, MD, Professor of Medicine and Director, Duke AHEAD. Education research: Interprofessional teams, wellness and resilience, learning environment, resident and medical student competency , curriculum development, faculty development, education innovation.
Leonor Corsino, MD, MHS, Associate Professor of Medicine. Dr. Corsino’s endocrine-related research focuses on diabetes and related co-morbidities with a particular interest in health disparities and Hispanic/Latino/Latinx populations. She has served as the PI and Co-Investigator in NIH, Industry and internal and external awards including the Hypertension Improvement Project-Latino, Latino Health Project, Cellphone Intervention for You, Patient and Provider Intervention for the Management of Osteoarthritis (PRIMO), PRIMO-Latino, Duke Diet and Fitness Center Duke Employee Weight Loss Program, SAVOR-TIMI 53, Durham Diabetes Coalition, A Self- Management Intervention for Women with Breast Cancer and Diabetes, Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients, and Transition of Care Model for adults Hispanic/Latino patients with diabetes from hospital to community, among many others.
Also, Dr. Corsino has a special interest in health professions education, and scientific workforce. Some of her work includes her collaboration in the NIH sponsored Peer group psychosocial mentoring and mechanisms of change contributing to personal gains and objective career outcomes for early-career biomedical Researchers, and the REACH Equity Center/Co- Director Training and Education Subscore. Further, Dr. Corsino projects include the Aime Global- Advancing Medical Education Globally, and the National Medical Spanish Standardized Curriculum study. Dr. Corsino and Dr. Velez-Rivera edited the Spanish version of the endocrine society COVID-19 resource page, and Dr. Corsino Ihas worked on articles in the society hormone network page.
Anastasia-Stefania Alexopoulos, MBBS, Assistant Professor of Medicine. Dr. Alexopoulos’s research centers on innovating diabetes care delivery to improve outcomes, particularly for patients at highest risk. She has a strong interest in advancing the detection and evidence-based management of metabolic dysfunction–associated steatotic liver disease (MASLD) among individuals with diabetes. Her work includes several observational studies that highlight gaps in current care, as well as a KL2-funded pilot study evaluating the feasibility of a telehealth intervention to help close these gaps. More broadly, Dr. Alexopoulos is interested in digital health and how emerging technologies can enhance care for individuals with diabetes and metabolic disease. She currently collaborates with colleagues in biomedical engineering to explore the use of wearables for early detection and prevention of diabetes and its complications. In addition, she has expertise in caring for older adults with diabetes and works with collaborators in geriatrics, endocrinology, and epidemiology to develop strategies that improve the safety and effectiveness of treatments in this population.